Carlyle is in talks to change sides as part of the reshuffle of bidders for Warner Chilcott, the Northern Irish pharmaceutical group whose value has climbed by 33% in six weeks.

Two sources close to the bidding war said the US private equity group is negotiating to join with Goldman Sachs and launch a new offer.